Concomitant medications during immune checkpoint blockage in cancer patients: novel insights in this emerging clinical scenario

G Rossi, A Pezzuto, C Sini, A Tuzi, F Citarella… - Critical Reviews in …, 2019 - Elsevier
The use of immune checkpoint inhibitors (ICIs) in cancer patients is rapidly growing.
However, the potential impact of some widely used concomitant medications is still largely …

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: when common sense is not enough

M Bersanelli, S Buti, U De Giorgi, M Di Maio… - Critical reviews in …, 2019 - Elsevier
Influenza vaccination is recommended for advanced cancer patients, since impaired
immunity is presumed to be due not only to the tumor itself but also to immunosuppressive …

Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen.(III) Impfen bei hämatologischen und …

HJ Laws, U Baumann, C Bogdan, G Burchard… - 2020 - Springer
In Deutschland leben aktuell circa 4 Mio. Menschen, die in ihrem Leben eine
Krebserkrankung diagnostiziert bekommen haben [171]. Im Zeitraum von 1980–2017 …

Influenza vaccination and myo-pericarditis in patients receiving immune checkpoint inhibitors: investigating the likelihood of interaction through the Vaccine Adverse …

M Gatti, E Raschi, U Moretti, A Ardizzoni, E Poluzzi… - Vaccines, 2021 - mdpi.com
Background: Evidence on whether the influenza vaccine could exacerbate immune-related
adverse events, including myopericarditis (MP), in patients treated with immune checkpoint …

Precision medicine and the principle of equal treatment: a conjoint analysis

EJ Tranvåg, R Strand, T Ottersen, OF Norheim - BMC medical ethics, 2021 - Springer
Background In precision medicine biomarkers stratify patients into groups that are offered
different treatments, but this may conflict with the principle of equal treatment. While some …

Stimuli‐responsive nanoparticles for the codelivery of chemotherapeutic agents doxorubicin and siPD‐L1 to enhance the antitumor effect

Y Zhou, W Wan, Y Tong, M Chen… - … Research Part B …, 2020 - Wiley Online Library
Cancer cells have been reported to exhibit high resistance against immune system
recognition through various cell intrinsic and extrinsic mechanisms. Considerable …

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: the PRACTICE study

M Bersanelli, E Lattanzi, N D'Abbiero… - Biomedical …, 2020 - spandidos-publications.com
In the present study, the influence of purely palliative radiotherapy (pRT) on the outcomes of
patients with advanced cancer undergoing immune checkpoint blockade was evaluated …

[HTML][HTML] PD-1/PD-L1 inhibitors for non–small cell lung cancer: Incorporating Care Step Pathways for effective side-effect management

MJ Davies - Journal of the Advanced Practitioner in Oncology, 2019 - ncbi.nlm.nih.gov
Programmed cell death protein 1 receptor and programmed cell death ligand 1 (PD-L1)
inhibitors are immune checkpoint inhibitors (ICIs) that provide a survival benefit for select …

La vaccination des communautés vulnérables en pharmacie communautaire au Québec suite à l'adoption du projet de loi 31

A Chadi - 2023 - papyrus.bib.umontreal.ca
Dans les dernières décennies, les taux de vaccination dans les différentes provinces
canadiennes n'atteignent pas les objectifs fixés et stagnent. La pandémie de COVID-19 a …

[PDF][PDF] Schutzimpfungen und onkologische Therapie

M Schöne - multi-schulmedizin.mgo-fachverlage …
2. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen
Impfkommission empfohlenen Impfungen.(III) Impfen bei hämatologischen und …